肿瘤患者的心律失常：临床医生的简要概述。

Q4 Medicine

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-08-11 DOI:10.1007/s00399-024-01033-x

Konstantinos Iliodromitis, Mathias Hoiczyk, Nana-Yaw Bimpong-Buta, Melchior Seyfarth, Harilaos Bogossian

{"title":"肿瘤患者的心律失常：临床医生的简要概述。","authors":"Konstantinos Iliodromitis, Mathias Hoiczyk, Nana-Yaw Bimpong-Buta, Melchior Seyfarth, Harilaos Bogossian","doi":"10.1007/s00399-024-01033-x","DOIUrl":null,"url":null,"abstract":"Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"177-182"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Arrhythmias in oncological patients: a compact overview for the clinician.\",\"authors\":\"Konstantinos Iliodromitis, Mathias Hoiczyk, Nana-Yaw Bimpong-Buta, Melchior Seyfarth, Harilaos Bogossian\",\"doi\":\"10.1007/s00399-024-01033-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.\",\"PeriodicalId\":52403,\"journal\":{\"name\":\"Herzschrittmachertherapie und Elektrophysiologie\",\"volume\":\" \",\"pages\":\"177-182\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Herzschrittmachertherapie und Elektrophysiologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00399-024-01033-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Herzschrittmachertherapie und Elektrophysiologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00399-024-01033-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

化疗是恶性肿瘤患者抗肿瘤治疗的基石。抗肿瘤治疗的心脏毒性作用已为人所知数十年。化疗引起的心脏毒性包括心律紊乱。这篇简短的综述旨在为临床心脏病学家提供一个简明的概述，介绍抗肿瘤药物在癌症幸存者中造成心律失常的可能性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Arrhythmias in oncological patients: a compact overview for the clinician.

Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Herzschrittmachertherapie und Elektrophysiologie Medicine-Cardiology and Cardiovascular Medicine

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： Mit wissenschaftlichen Original- und Übersichtsarbeiten, Berichten über moderne Operationstechniken und experimentelle Methoden ist die Zeitschrift Herzschrittmachertherapie + Elektrophysiologie ein Diskussionsforum für Themen wie: - Zelluläre Elektrophysiologie - Theoretische Elektrophysiologie - Klinische Elektrophysiologie - Angewandte Herzschrittmachertherapie - Bradykarde und tachykarde Herzrhythmusstörungen - Plötzlicher Herztod und Risikostratifikation - Elektrokardiographie - Elektromedizinische Technologie - Experimentelle und klinische Pharmakologie - Herzchirurgie bei Herzrhythmusstörungen Mitteilungen der Arbeitsgruppen Herzschrittmacher und Arrhythmie der Deutschen Gesellschaft für Kardiologie - Herz und Kreislaufforschung e.V. (DGK) sowie Stellungnahmen und praktische Hinweise runden das breite Spektrum dieser Zeitschrift ab. Interessensgebiete: Kardiologie, Herzschrittmachertherapie, Herzschrittmachertechnologie, klinische Elektrophysiologie